Cart 0

MarketsandMarkets

Life Science Analytics Market- Forecasts to 2021

$5,650.00

Report Published By: MarketsandMarkets
Publication Date : Jan-17
No. Of Pages: 179

The global life science analytics market is expected to reach USD 24.73 billion by 2021 from USD 13.26 billion in 2016, at a CAGR of 13.3% from 2016 to 2021.
Major factors contributing to the growth of the global life science analytics market include technological advancements, availability of big data in the life science industry, growing adoption of analytics solutions for clinical trials, increasing adoption of analytics solutions for sales and marketing applications, growing need for improved data standardization, rising prevalence of chronic diseases, increasing pressure to curb healthcare spending, and growing need for improved patient outcomes. Moreover, increasing focus on value-based medicine, use of analytics in precision and personalized medicine, cloud-based analytics, use of big data analytics to increase R&D productivity, and emergence of social media and its impact on the life science industry provide significant growth opportunities in the market. However, lack of skilled professionals and financial constraints may hinder the growth of this market during the forecast period.
Various companies are focusing on technological advancements to improve the life science industry. Life science companies are increasingly adopting digitization in order to increase productivity and profitability. To leverage growth opportunities many of the players in the market are innovating and upgrading their portfolios. For instance, in April 2016, Oracle Corporation (U.S.) launched the cloud version of its Oracle Health Sciences Safety Suite 8.0. This solution provides end-to-end safety management and business analytics/intelligence to pharma companies.
Asia is projected to be fastest-growing region in the market during the forecast period. High growth in this region can be attributed to factors such as large population base, growing prevalence of chronic diseases, increasing need for innovative therapies, and low manufacturing costs in the region. Moreover, growing focus on the adoption of digital technology in life science manufacturing and R&D activities is expected to boost the life science analytics market in Asia.
Research Coverage:
This market is categorized on the basis of type, application, component, delivery model, end user, and region. Apart from comprehensive geographical analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players in the last three years. In addition, the company profiles comprise basic views on the key players and their product portfolios, developments, and strategies adopted. The abovementioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, changes in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of top players in the life science analytics market. The report analyzes this market by type, application, component, delivery model, end user, and region
• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the life science analytics market
• Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in the life science analytics market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for life science analytics across regions
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the life science analytics market

TABLE OF CONTENTS

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 19
1.3.1 MARKETS COVERED 19
1.3.2 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY 20
1.5 LIMITATIONS 20
1.6 STAKEHOLDERS 20
2 RESEARCH METHODOLOGY 21
2.1 MARKET SIZE ESTIMATION 22
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 26
2.3 KEY INDUSTRY INSIGHTS 28
2.4 ASSUMPTIONS FOR THE STUDY 28
3 EXECUTIVE SUMMARY 29
3.1 INTRODUCTION 29
3.2 CONCLUSION 33
4 PREMIUM INSIGHTS 34
4.1 LIFE SCIENCE ANALYTICS MARKET OVERVIEW 34
4.2 LIFE SCIENCE ANALYTICS MARKET, BY TYPE 34
4.3 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION 35
4.4 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT 35
4.5 LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL 36
4.6 LIFE SCIENCE ANALYTICS MARKET, BY END USER 36
4.7 GEOGRAPHIC SNAPSHOT: LIFE SCIENCE ANALYTICS MARKET 37
5 MARKET OVERVIEW 38
5.1 INTRODUCTION 39
5.2 MARKET DYNAMICS 39
5.2.1 DRIVERS 40
5.2.1.1 Technological advancements 40
5.2.1.2 Availability of big data in the life science industry 40
5.2.1.3 Growing adoption of analytics solutions in clinical trials 41
5.2.1.4 Increasing adoption of analytics for sales and marketing applications 41
5.2.1.5 Need for improved data standardization 42
5.2.1.6 Increasing prevalence of chronic diseases 42
5.2.1.7 Growing pressure to curb healthcare spending and the need for improved patient outcomes 43
5.2.2 RESTRAINTS 44
5.2.2.1 Dearth of skilled personnel 44
5.2.2.2 High implementation costs 44
5.2.3 OPPORTUNITIES 45
5.2.3.1 Increasing focus on value-based medicine 45
5.2.3.2 Use of analytics in precision and personalized medicine 45
5.2.3.3 Cloud-based analytics 46
5.2.3.4 Use of big data analytics to increase R&D productivity 46
5.2.3.5 Emergence of social media and its impact on the life science industry 46
5.2.4 CHALLENGES 47
5.2.4.1 Data privacy issues 47
5.2.4.2 Data integration in the life science ecosystem 47
6 LIFE SCIENCE ANALYTICS MARKET, BY TYPE 49
6.1 INTRODUCTION 50
6.2 DESCRIPTIVE ANALYTICS 51
6.3 PREDICTIVE ANALYTICS 53
6.4 PRESCRIPTIVE ANALYTICS 55
7 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION 57
7.1 INTRODUCTION 58
7.2 RESEARCH AND DEVELOPMENT 59
7.2.1 PRECLINICAL TRIALS 61
7.2.2 CLINICAL TRIALS 63
7.3 SALES AND MARKETING SUPPORT 65
7.4 REGULATORY COMPLIANCE 67
7.5 SUPPLY CHAIN ANALYTICS 69
7.6 PHARMACOVIGILANCE 71
8 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT 73
8.1 INTRODUCTION 74
8.2 SERVICES 75
8.3 SOFTWARE 78
9 LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL 81
9.1 INTRODUCTION 82
9.2 ON-PREMISE DELIVERY MODELS 83
9.3 ON-DEMAND DELIVERY MODELS 85
?
10 LIFE SCIENCE ANALYTICS MARKET, BY END USER 88
10.1 INTRODUCTION 89
10.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 90
10.3 MEDICAL DEVICE COMPANIES 92
10.4 RESEARCH CENTERS 94
10.5 THIRD-PARTY ADMINISTRATORS 95
11 LIFE SCIENCE ANALYTICS MARKET, BY REGION 97
11.1 INTRODUCTION 98
11.2 NORTH AMERICA 99
11.2.1 U.S. 102
11.2.2 CANADA 106
11.3 EUROPE 109
11.3.1 GERMANY 112
11.3.2 FRANCE 115
11.3.3 U.K. 118
11.3.4 REST OF EUROPE 121
11.4 ASIA 124
11.5 REST OF THE WORLD 128
12 COMPETITIVE LANDSCAPE 132
12.1 OVERVIEW 132
12.2 MARKET ANALYSIS 133
12.3 COMPETITIVE SITUATION AND TRENDS 135
12.3.1 PRODUCT AND SERVICE LAUNCHES, UPGRADES, AND ENHANCEMENTS 135
12.3.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 136
12.3.3 EXPANSIONS 137
12.3.4 MERGERS AND ACQUISITIONS 138
13 COMPANY PROFILES 139
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 INTRODUCTION 139
13.2 SAS INSTITUTE INC. 140
13.3 IBM CORPORATION 143
13.4 ORACLE CORPORATION 146
13.5 QUINTILES, INC. 149
13.6 ACCENTURE 152
13.7 COGNIZANT 155
13.8 MAXISIT 157
13.9 SCIO HEALTH ANALYTICS 158
?
13.10 TAKE SOLUTIONS 159
13.11 WIPRO LIMITED 161

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
14 APPENDIX 163
14.1 INSIGHTS FROM INDUSTRY EXPERTS 163
14.2 DISCUSSION GUIDE 164
14.3 OTHER DEVELOPMENTS 168
14.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 172
14.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 174
14.6 AVAILABLE CUSTOMIZATIONS 175
14.7 RELATED REPORTS 176
14.8 AUTHOR DETAILS 177

* indicates required information

* indicates required information


Share this Product


More from this collection